Short answer · Medically reviewed summary · Last updated: 2026-05-08
Cockayne syndrome is primarily classified under ICD-10 code Q87.1, which covers congenital malformation syndromes predominantly associated with short stature, and it does not have a unique, dedicated ICD-9 code, often being grouped under 759.89 (other specified congenital anomalies). Because Cockayne syndrome is a rare multisystem disorder, these diagnostic codes are essential for healthcare documentation and insurance billing, though they provide limited insight into the complex clinical management required for patients. What are the primary medical challenges in Cockayne syndrome? Cockayne syndrome is a rare, autosomal recessive disorder characterized by failure to thrive, neurological impairment, and extreme sensitivity to sunlight.
ICD10 code of Cockayne Syndrome and ICD9 code
ICD-10 and ICD-9 codes for Cockayne Syndrome, with classification details for clinicians, coders and patients.
Cockayne syndrome is primarily classified under ICD-10 code Q87.1, which covers congenital malformation syndromes predominantly associated with short stature, and it does not have a unique, dedicated ICD-9 code, often being grouped under 759.89 (other specified congenital anomalies). Because Cockayne syndrome is a rare multisystem disorder, these diagnostic codes are essential for healthcare documentation and insurance billing, though they provide limited insight into the complex clinical management required for patients.
What are the primary medical challenges in Cockayne syndrome?
Cockayne syndrome is a rare, autosomal recessive disorder characterized by failure to thrive, neurological impairment, and extreme sensitivity to sunlight. Patients with Cockayne syndrome often face premature aging symptoms, including sensorineural hearing loss, cataracts, and progressive white matter changes in the brain. Because there are currently only two members within the DiseaseMaps.org community living with this condition, we recognize that families often feel isolated while navigating the complex care requirements of Cockayne syndrome.
How is Cockayne syndrome diagnosed and managed?
Diagnosis of Cockayne syndrome typically involves clinical evaluation followed by molecular genetic testing to identify pathogenic variants in the ERCC6 or ERCC8 genes. Management is entirely supportive and multidisciplinary, focusing on the following areas:
- Dermatology: Strict protection from UV light to prevent severe photosensitivity reactions.
- Nutrition: Gastrostomy tube feeding is frequently required to manage severe growth failure.
- Neurology: Ongoing monitoring for progressive neurodegeneration and seizure management.
- Physical Therapy: Interventions to maintain mobility and address joint contractures.
Is Cockayne syndrome hereditary?
Yes, Cockayne syndrome is an inherited condition passed down in an autosomal recessive pattern. This means that both parents must be carriers of a mutation in the relevant gene for a child to be affected, resulting in a 25% chance of recurrence in each pregnancy. Genetic counseling is strongly recommended for families affected by Cockayne syndrome to understand these risks and explore reproductive options.
Next steps
- Consult a clinical geneticist to confirm the diagnosis and discuss family planning.
- Coordinate care through a center of excellence specializing in DNA repair disorders or pediatric neuro-metabolic diseases.
- Connect with the DiseaseMaps.org community to share resources with other families facing similar rare disease challenges.
Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment from a qualified healthcare provider.
References
- Orphanet: Cockayne syndrome (ORPHA:187)
- NIH Genetic and Rare Diseases Information Center (GARD): Cockayne syndrome
- OMIM: Cockayne Syndrome (Entry #216400)
- GeneReviews: Cockayne Syndrome Overview
